An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

(2010) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

(2010) W. Zhang et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer

(2010) S. M. Lipkin et al.   Cancer Prevention Research

Bcl9/Bcl9l Are Critical for Wnt-Mediated Regulation of Stem Cell Traits in Colon Epithelium and Adenocarcinomas

(2010) J. Deka et al.   CANCER RESEARCH

Colon Cancer Stem Cells: Promise of Targeted Therapy

(2010) Matilde Todaro et al.   GASTROENTEROLOGY

Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer

(2010) Kyong-Ah Yoon et al.   Journal of Thoracic Oncology

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis

(2010) Cheng-Gang Wang   WORLD JOURNAL OF GASTROENTEROLOGY

Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

(2009) Santiago Rodriguez et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Characterization of UGTs Active against SAHA and Association between SAHA Glucuronidation Activity Phenotype with UGT Genotype

(2009) R. M. Balliet et al.   CANCER RESEARCH

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

(2009) N. A. Dallas et al.   CANCER RESEARCH

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

(2009) George J. Klarmann et al.   CLINICAL & EXPERIMENTAL METASTASIS

Epigenetic gene regulation in stem cells and correlation to cancer

(2009) Lesley A. Mathews et al.   DIFFERENTIATION

Palliative treatment of unresectable metastatic colorectal cancer

(2009) Lorenzo Fornaro et al.   EXPERT OPINION ON PHARMACOTHERAPY

Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines

(2009) F. Crea et al.   MOLECULAR CANCER THERAPEUTICS

Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer

(2009) C.-H. Kohne et al.   ONCOLOGIST

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Growth inhibition of colon cancer cells by polyisoprenylated benzophenones is associated with induction of the endoplasmic reticulum response

(2008) Petr Protiva et al.   INTERNATIONAL JOURNAL OF CANCER

Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding

(2008) Z. Shen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

ERp29 is a Radiation-Responsive Gene in IEC-6 Cell

(2008) Bo ZHANG et al.   JOURNAL OF RADIATION RESEARCH

Roles of the EZH2 histone methyltransferase in cancer epigenetics

(2008) Jeffrey A. Simon et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

(2008) Q Cao et al.   ONCOGENE